CHRISTINE DURBIN: Open Payments
NPI 1689735128 · SAINT JAMES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 35 payments from 13 companies in 2025. Trend: 2023 $468 · 2024 $465 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $153 |
| Novo Nordisk Inc | 4 | $139 |
| ABBVIE INC. | 5 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $108 |
| Abbott Laboratories | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Ozempic, CAPLYTA, FREESTYLE LIBRE, REPATHA, VRAYLAR, REXULTI, OTEZLA, UBRELVY.
Industry payments across MO — which companies pay providers there.
